EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Network pharmacology and experimental verification to decode the action of Qing Fei Hua Xian Decotion against pulmonary fibrosis

Hao-Liang Ke, Rui-Jie Li, Chao-Chao Yu, Xiu-Ping Wang, Chao-Yan Wu, Ying-Wen Zhang iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0305903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Hao-Liang Ke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Chinese and Western Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Drugs, Chinese Herbal, Network Pharmacology, Protein Interaction Maps. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Program of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary fibrosis (PF) is a common interstitial pneumonia disease, also occurred in post-COVID-19 survivors. The mechanism underlying the anti-PF effect of Qing Fei Hua Xian Decotion (QFHXD), a traditional Chinese medicine formula applied for treating PF in COVID-19 survivors, is unclear. This study aimed to uncover the mechanisms related to the anti-PF effect of QFHXD through analysis of network pharmacology and experimental verification.

Methods

The candidate chemical compounds of QFHXD and its putative targets for treating PF were achieved from public databases, thereby we established the corresponding “herb-compound-target” network of QFHXD. The protein–protein interaction network of potential targets was also constructed to screen the core targets. Furthermore, Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were used to predict targets, and pathways, then validated by in vivo experiments.

Results

A total of 188 active compounds in QFHXD and 50 target genes were identified from databases. The key therapeutic targets of QFHXD, such as PI3K/Akt, IL-6, TNF, IL-1β, STAT3, MMP-9, and TGF-β1 were identified by KEGG and GO analysis. Anti-PF effects of QFHXD (in a dose-dependent manner) and prednisone were confirmed by HE, Masson staining, and Sirius red staining as well as in vivo Micro-CT and immunohistochemical analysis in a rat model of bleomycin-induced PF. Besides, QFXHD remarkably inhibits the activity of PI3K/Akt/NF-κB and TGF-β1/Smad2/3.

Conclusions

QFXHD significantly attenuated bleomycin-induced PF via inhibiting inflammation and epithelial-mesenchymal transition. PI3K/Akt/NF-κB and TGF-β1/Smad2/3 pathways might be the potential therapeutic effects of QFHXD for treating PF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisDrugs, Chinese HerbalNetwork PharmacologyProtein Interaction MapsAnimalsRatsMaleBleomycinTransforming Growth Factor beta1Rats, Sprague-DawleySignal TransductionHumansCOVID-19Epithelial-Mesenchymal TransitionMedicine, Chinese TraditionalCOVID-19 Drug Treatment

Substanzen

Drugs, Chinese HerbalBleomycinTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Integrated Chinese and Western Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • School of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
  • Department of Rehabilitation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Ying-Wen Zhang

Förderung

  • Science and Technology Program of Hubei Province

Zitieren

APA

Ke, H. L., Li, R. J., Yu, C. C., Wang, X. P., Wu, C. Y., & Zhang, Y. W. (2024). Network pharmacology and experimental verification to decode the action of Qing Fei Hua Xian Decotion against pulmonary fibrosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0305903

Vancouver

Ke HL, Li RJ, Yu CC, Wang XP, Wu CY, Zhang YW. Network pharmacology and experimental verification to decode the action of Qing Fei Hua Xian Decotion against pulmonary fibrosis. PLOS ONE. 2024. doi:10.1371/journal.pone.0305903

BibTeX
@article{Ke2024,
  author = {Ke, Hao-Liang and Li, Rui-Jie and Yu, Chao-Chao and Wang, Xiu-Ping and Wu, Chao-Yan and Zhang, Ying-Wen},
  title = {Network pharmacology and experimental verification to decode the action of Qing Fei Hua Xian Decotion against pulmonary fibrosis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0305903}
}
Kostenlos starten →